Biotech

All Articles

FibroGen lays off 75% people staff as possession fails 2 additional tests

.FibroGen is actually drastically reorganizing its own organization, laying off 75% of its USA worke...

Tracon unwind weeks after injectable PD-L1 prevention stop working

.Tracon Pharmaceuticals has made a decision to wind down procedures weeks after an injectable immune...

Ideaya bags option on Biocytogen bispecific ADC in $400M package

.Ideaya Biosciences is actually betting $400 million in biobucks that a bispecific antibody-drug con...

Takeda takes $140M reduction on stopped working epilepsy medicine, proclaims FDA run

.Our company currently know that Takeda is actually hoping to discover a pathway to the FDA for epil...

VBI Injections apply for insolvency, seeks possession sale

.Immunology biotech VBI Injections is drifting precariously close to the defining moment, along with...

Celldex anti-cKIT antibody reduce colonies in another period 2 study

.It's hard to muscular tissue in on a space as competitive as immunology, however Celldex Therapeuti...

Boehringer offers up to $1.3 B for checkpoint inhibitor biotech

.Boehringer Ingelheim is actually offering up to $1.3 billion for Nerio Therapeutics and a preclinic...

Ventyx's last hope for inflamed med ends in Crohn's failing

.Ventyx Biosciences' Crohn's disease medicine did certainly not aid patients achieve remission in a ...

Cognition's stage 2 radiate records tarnish Alzheimer's prospect

.Knowledge Rehabs' stage 2 luster trial has actually taken a number of the luster off the Alzheimer'...

BMS axes bispecific months after filing to run phase 3 trial

.Bristol Myers Squibb has actually had a whiplash change of mind on its BCMA bispecific T-cell engag...